Background

The World Health Organization (WHO) reports that epilepsy, which affects about 50 million people globally and raises the risk of early death, is one of the most prevalent neurological conditions. However, when properly identified and treated, about 70% of epilepsy sufferers are seizure-free. Seizures produced by epilepsy emerge from numerous parts of the brain and are characterized by aberrant electrical signals brought on by damaged proteins. A mutation in one of the genes that codes for these proteins is present in roughly 30 to 40 percent of epilepsy sufferers. These mutations can cause early-onset cerebellar ataxia, intellectual disability, developmental delay, and mobility abnormalities in addition to epilepsy.

The main protein responsible for the electrical signal in the brain and